Actively Recruiting
Study of Umbilical Cord Blood-Supported Haploidentical Stem Cell Transplantation Compared to Matched Sibling Transplantation for Treating Aplastic Anemia
Led by Shanxi Bethune Hospital · Updated on 2025-08-14
110
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Aplastic anemia AA is a rare condition where the bone marrow fails to produce enough blood cells, affecting people of all ages but more commonly the elderly. This study evaluates a new treatment approach for AA by comparing umbilical cord blood-supported haploidentical hematopoietic stem cell transplantation haplo-HSCT with the standard sibling fully matched transplantation. The goal is to assess the safety and effectiveness of this combined method, focusing on infection rates, graft-versus-host disease GVHD, transplant-related mortality TRM, and event-free survival EFS. Participants diagnosed with severe aplastic anemia SAA, transfusion-dependent non-severe aplastic anemia TD-NSAA, or paroxysmal nocturnal hemoglobinuria PNH will receive either the umbilical cord blood-supported haplo-HSCT or sibling matched transplantation. The study uses a conditioning regimen specific to AA severity and includes medications to prevent GVHD. Umbilical cord blood stem cells are infused four hours before peripheral blood stem cells in the haplo-HSCT group. This open-label, parallel-controlled trial compares outcomes like neutrophil engraftment time, platelet recovery, infections including CMV and EBV, GVHD, TRM, and survival rates. Throughout the study, participants will be monitored closely for blood cell recovery, infections, and potential complications. Data on neutrophil and platelet engraftment will be collected within 60 days, while infection rates, GVHD incidence, mortality, and survival will be tracked up to 24 months. Follow-up assessments ensure the quality of data and participant safety, helping researchers understand the feasibility and risks of this treatment and potentially improve care options for AA patients.
CONDITIONS
Brief Title
Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study
Research Team
T
Tao Wang, Dr.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here